FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to neurology, obstetrics, gynecology, laboratory diagnostics, and can be used to diagnose cognitive impairment in pregnant women with hypertensive disorders. The concentration of brain-derived neurotrophic factor (BDNF) is determined in blood serum. If its value is equal to or higher than 16.3 ng/ml, cognitive impairment is diagnosed in pregnant women with hypertensive disorders.
EFFECT: method provides the possibility of objectification, speed of implementation, increase in the accuracy of diagnosis of cognitive impairment in pregnant women with hypertensive disorders, increase in specificity and sensitivity due to the determination of BDNF concentration in blood.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING SEVERE COMPLICATIONS OF PREECLAMPSIA | 2020 |
|
RU2741730C1 |
| METHOD FOR PREDICTING EPH-GESTOSIS IN PREGNANT WOMEN SUFFERING FROM HYPERTENSION | 2004 |
|
RU2256180C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF HYPERTENSIVE STATES IN PREGNANCY | 2012 |
|
RU2499547C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF HYPERTENSIVE DISORDERS DURING PREGNANCY | 2010 |
|
RU2444280C2 |
| METHOD OF MORPHOLOGICAL DIAGNOSIS OF THE SEVERITY OF PREECLAMPSIA | 2017 |
|
RU2682251C1 |
| METHOD FOR DIAGNOSING SEVERE GESTOSIS FORMS | 2003 |
|
RU2259568C2 |
| METHOD FOR PREDICTION OF DEPRESSION PROGRESSION IN PREGNANT WOMEN SUFFERED MISCARRIAGE IN PAST MEDICAL HISTORY | 2014 |
|
RU2565742C1 |
| METHOD OF ESTIMATING RISK TO PREGNANCY IN PRENATAL PERIOD BY RESULTS OF MASS MONITORING OF PREGNANT WOMEN AT REGIONAL LEVEL | 2012 |
|
RU2497437C1 |
| METHOD FOR PREDICTING CEREBRAL ISCHEMIA IN NEWBORNS BORN TO MOTHERS WITH PREECLAMPSIA | 2021 |
|
RU2777225C1 |
| DIAGNOSTIC TECHNIQUE FOR FUNCTIONAL CHANGES OF VASOACTIVE STATUS OF PREGNANT WOMAN IN EARLY PREECLAMPSIA | 2023 |
|
RU2825534C1 |
